The "nonamyloidogenic" p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid.

The Journal of Biological Chemistry
M LalowskiT M Wisniewski

Abstract

Down's syndrome (DS) patients show accelerated Alzheimer's disease (AD) neuropathology, which consists of preamyloid lesions followed by the development of neuritic plaques and neurofibrillary tangles. The major constituents of preamyloid and neuritic plaques are amyloid beta (Abeta) peptides. Preamyloid lesions are defined as being Abeta immunoreactive lesions, which unlike neuritic plaque amyloid are Congo red-negative and largely nonfibrillar ultrastructurally. DS patients can develop extensive preamyloid deposits in the cerebellum, without neuritic plaques; hence, DS cerebellums are a source of relatively pure preamyloid. We biochemically characterized the composition of DS preamyloid and compared it to amyloid in the neuritic plaques and leptomeninges in the same patients. We found that Abeta17-42 or p3 is a major Abeta peptide of DS cerebellar preamyloid. This 26-residue peptide is also present in low quantities in neuritic plaques. We suggest that preamyloid can now be defined biochemically as lesions in which a major Abeta peptide is p3.

References

Nov 5, 1992·Journal of Molecular Biology·S DasguptaS Burnett
Mar 5, 1991·Journal of Molecular Biology·C HilbichK Beyreuther
Jan 1, 1989·Acta Neuropathologica·H M WisniewskiJ Currie
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther
Aug 1, 1988·Journal of Neurochemistry·F PrelliB Frangione
May 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
Nov 18, 1995·Lancet·T WisniewskiB Frangione
Oct 13, 1995·The Journal of Biological Chemistry·C J PikeC W Cotman
Mar 1, 1995·Annals of Neurology·S G Younkin
Apr 15, 1995·Lancet·T WisniewskiB Frangione
Mar 1, 1994·Neurobiology of Aging·T WisniewskiB Frangione
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·K C EvansP T Lansbury
Oct 27, 1994·Neuroreport·F YangG M Cole
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·A Lorenzo, B A Yankner
May 16, 1994·Biochemical and Biophysical Research Communications·M TabatonP Gambetti
Oct 1, 1993·Annals of Neurology·H A CrystalP Antis
Nov 1, 1993·Journal of Neurochemistry·C Vigo-PelfreyD B Schenk

❮ Previous
Next ❯

Citations

Sep 7, 2007·Acta Neuropathologica·John C Fiala
Jul 3, 2007·Journal of the American Society for Mass Spectrometry·Sarah Trimpin, Max L Deinzer
Feb 17, 1998·Trends in Neurosciences·R L Neve, N K Robakis
Sep 27, 2012·Journal of Medicinal Chemistry·Laura C LópezJavier Sancho
Nov 5, 2002·Nature Reviews. Neuroscience·Frank M LaFerla
Mar 2, 2013·Physical Chemistry Chemical Physics : PCCP·Hyunbum JangRuth Nussinov
Mar 16, 2013·Physical Chemistry Chemical Physics : PCCP·Xiang YuJie Zheng
Mar 24, 2010·Proceedings of the National Academy of Sciences of the United States of America·Hyunbum JangRatnesh Lal
Mar 15, 2008·Brain : a Journal of Neurology·Milos D IkonomovicSteven T DeKosky
Dec 16, 1996·Annals of the New York Academy of Sciences·Y J KwonN R Relkin
Nov 5, 2002·Annual Review of Pharmacology and Toxicology·Dennis J Selkoe, Dale Schenk
Apr 30, 2011·Molecular Neurodegeneration·Hui Zheng, Edward H Koo
Feb 16, 2000·Biochemical and Biophysical Research Communications·D ElbaumD L Alkon
Jun 1, 2007·Biomarkers in Medicine·Ulf AndreassonHenrik Zetterberg
Mar 19, 2005·Journal of Neurochemistry·Hyang-Sook HoeG William Rebeck
Jan 1, 1997·Critical Reviews in Biochemistry and Molecular Biology·R Kisilevsky, P E Fraser
Apr 27, 2007·Neurobiology of Aging·Ihsen YoussefThierry Pillot
Jun 29, 2001·Journal of Peptide Science : an Official Publication of the European Peptide Society·A B ClippingdaleC J Barrow
Jul 16, 2008·Journal of Cellular and Molecular Medicine·Dietmar Rudolf ThalHeiko Braak
Mar 27, 2018·Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry·Hyunsung ChoiSungsoo Na
Oct 16, 2010·Neuropathology and Applied Neurobiology·J AttemsW Van Nostrand
Jul 13, 2013·FEBS Letters·Pavan K GhattyVenkataKrishnaXiaolin Cheng
Mar 22, 2014·Neuroscience Bulletin·Evan DoreyWandong Zhang
Aug 6, 2019·Developmental Neurobiology·Eric E AbrahamsonMilos D Ikonomovic
Feb 27, 2015·Biomolecular Concepts·Khue Vu Nguyen
May 17, 2005·Journal of Neuropathology and Experimental Neurology·Deng-Shun WangDennis W Dickson
Aug 1, 1998·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·D B Teplow

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.